![Philippe Crine](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philippe Crine
Fundador en PreciThera, Inc. .
Cargos activos de Philippe Crine
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Institut de recherches cliniques de Montréal
![]() Institut de recherches cliniques de Montréal Miscellaneous Commercial ServicesCommercial Services Institut de recherches cliniques de Montréal operates as an independent non-profit research institution focusing on biomedical research. The firm excels in basic research of economic development in the fields of pharmaceuticals, biotechnology and health services. The company was founded in 1967 and is headquartered in Montr?al, Canada. | Director/Miembro de la Junta | 15/12/2015 | - |
PreciThera, Inc.
![]() PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada. | Director/Miembro de la Junta | 26/05/2016 | - |
Director de Operaciones | 26/05/2016 | - | |
Fundador | 26/05/2016 | - |
Historial de carrera de Philippe Crine
Antiguos cargos conocidos de Philippe Crine.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Director Técnico/Científico/I+D | - | - |
Fundador | - | - |
Formación de Philippe Crine.
University of Montréal | Doctorate Degree |
Estadísticas
Internacional
Canadá | 5 |
Operativa
Founder | 2 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Enobia Pharma, Inc.
![]() Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Technology |
Institut de recherches cliniques de Montréal
![]() Institut de recherches cliniques de Montréal Miscellaneous Commercial ServicesCommercial Services Institut de recherches cliniques de Montréal operates as an independent non-profit research institution focusing on biomedical research. The firm excels in basic research of economic development in the fields of pharmaceuticals, biotechnology and health services. The company was founded in 1967 and is headquartered in Montr?al, Canada. | Commercial Services |
PreciThera, Inc.
![]() PreciThera, Inc. Pharmaceuticals: MajorHealth Technology Precithera, Inc. engages in drug development business. The firm focuses on the design and the development of biological agents for the treatment of orphan diseases. The company was founded by Philippe Crine and Susan Schiavi on May 26, 2016 and is headquartered in Outremont, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Philippe Crine
- Experiencia